Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
Journal of Vascular Research
|
May 9, 2008
Effect of low molecular weight fucoidan and low molecular weight heparin in a rabbit model of arterial thrombosis
Eric Durand, Dominique Helley, Ayman Al Haj Zen, et al.
International Journal of Laboratory Hematology
|
May 28, 2024
DOAC-Remove to counteract the interference of anti-Xa oral anticoagulants on the monitoring of heparin
Sophie Melicine, Capucine Habay, Wiame Ghammad, et al.
Annales De Biologie Clinique
|
June 4, 2024
[Interference of oral anti-Xa anticoagulants during monitoring of unfractionated heparin treatments: practical and future attitudes]
Sophie Melicine, Laure Maucorps, Valérie Eschwège, et al.
Stem Cell Reviews and Reports
|
May 5, 2026
Circulating Biomarkers of Vascular Regeneration are not Associated with Residual Pulmonary Vascular Obstruction after Pulmonary Embolism: A Retrospective Observational Biomarker Study
Menfild Margotonne, Nicolas Gendron, Olivier Sanchez, et al.
Marine Drugs
|
December 24, 2015
Low-Molecular-Weight Fucoidan Induces Endothelial Cell Migration via the PI3K/AKT Pathway and Modulates the Transcription of Genes Involved in Angiogenesis
Claire Bouvard, Isabelle Galy-Fauroux, Françoise Grelac, et al.
European Urology
|
January 23, 2009
Salvage therapy with bevacizumab-sunitinib combination after failure of sunitinib alone for metastatic renal cell carcinoma: a case series
Jacques Medioni, Eugeniu Banu, Dominique Helley, et al.
Annales De Biologie Clinique
|
September 6, 2024
[Implementation of edoxaban anti-Xa activity assay in a hospital laboratory and evaluation of its analytical performance]
Corentin S Lefebvre, Sophie Luneau, Nûn Kalim Bentounes, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 30, 2022
Clinical, biological, and genetic features in an afibrinogenemia patient series in Algeria
Soraya Hadjali-Saichi, Philippe de Mazancourt, Jacqueline Tapon-Bretaudière, et al.
Stem Cell Reviews and Reports
|
March 14, 2025
Circulating CD34<sup>+</sup> Cells: A New Biomarker of Residual Pulmonary Vascular Obstruction after Pulmonary Embolism
Nicolas Gendron, Benjamin Planquette, Anne Roche, et al.
Therapie
|
March 17, 2021
Delayed thrombocytopenia following administration of abciximab: Pharmacovigilance survey and literature review
Louis Vincent, Delphine Bourneau-Martin, Anaïs Maurier, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
Journal of Vascular Research
|
May 9, 2008
Effect of low molecular weight fucoidan and low molecular weight heparin in a rabbit model of arterial thrombosis
Eric Durand, Dominique Helley, Ayman Al Haj Zen, et al.
International Journal of Laboratory Hematology
|
May 28, 2024
DOAC-Remove to counteract the interference of anti-Xa oral anticoagulants on the monitoring of heparin
Sophie Melicine, Capucine Habay, Wiame Ghammad, et al.
Annales De Biologie Clinique
|
June 4, 2024
[Interference of oral anti-Xa anticoagulants during monitoring of unfractionated heparin treatments: practical and future attitudes]
Sophie Melicine, Laure Maucorps, Valérie Eschwège, et al.
Stem Cell Reviews and Reports
|
May 5, 2026
Circulating Biomarkers of Vascular Regeneration are not Associated with Residual Pulmonary Vascular Obstruction after Pulmonary Embolism: A Retrospective Observational Biomarker Study
Menfild Margotonne, Nicolas Gendron, Olivier Sanchez, et al.
Marine Drugs
|
December 24, 2015
Low-Molecular-Weight Fucoidan Induces Endothelial Cell Migration via the PI3K/AKT Pathway and Modulates the Transcription of Genes Involved in Angiogenesis
Claire Bouvard, Isabelle Galy-Fauroux, Françoise Grelac, et al.
European Urology
|
January 23, 2009
Salvage therapy with bevacizumab-sunitinib combination after failure of sunitinib alone for metastatic renal cell carcinoma: a case series
Jacques Medioni, Eugeniu Banu, Dominique Helley, et al.
Annales De Biologie Clinique
|
September 6, 2024
[Implementation of edoxaban anti-Xa activity assay in a hospital laboratory and evaluation of its analytical performance]
Corentin S Lefebvre, Sophie Luneau, Nûn Kalim Bentounes, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
April 30, 2022
Clinical, biological, and genetic features in an afibrinogenemia patient series in Algeria
Soraya Hadjali-Saichi, Philippe de Mazancourt, Jacqueline Tapon-Bretaudière, et al.
Stem Cell Reviews and Reports
|
March 14, 2025
Circulating CD34<sup>+</sup> Cells: A New Biomarker of Residual Pulmonary Vascular Obstruction after Pulmonary Embolism
Nicolas Gendron, Benjamin Planquette, Anne Roche, et al.
Therapie
|
March 17, 2021
Delayed thrombocytopenia following administration of abciximab: Pharmacovigilance survey and literature review
Louis Vincent, Delphine Bourneau-Martin, Anaïs Maurier, et al.
Page
of 6